Literature DB >> 32107367

Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018.

Gaston Djomand, Trista Bingham, Irene Benech, Mercy Muthui, Helen Savva, Stella Alamo, Chomnad Manopaiboon, Tisha Wheeler, Sasha Mital.   

Abstract

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the largest bilateral funder of human immunodeficiency virus (HIV) prevention and control programs worldwide, currently supports implementation of preexposure prophylaxis (PrEP) to reduce HIV incidence among persons at substantial risk for infection, including female sex workers, men who have sex with men (MSM), and transgender women (hereafter referred to as key populations). Recent estimates suggest that 54% of all global new HIV infections in 2018 occurred among key populations and their sexual partners (1). In 2016, PEPFAR began tracking initiation of PrEP by key populations and other groups at high risk (2). The implementation and scale-up of PrEP programs across 35 PEPFAR-supported country or regional programs* was assessed by determining the number of programs reporting any new PrEP clients during each quarter from October 2016 to September 2018. As of September 2018, only 15 (43%) PEPFAR-supported country or regional programs had implemented PrEP programs; however, client volume increased by 3,351% over the assessment period in 15 country or regional programs. Scale-up of PrEP among general population clients (5,255%) was nearly three times that of key population clients (1,880%). Among key populations, the largest increase (3,518%) occurred among MSM. Factors that helped drive the success of these PrEP early adopter programs included initiation of national, regional, and multilateral stakeholder meetings; engagement of ministries of health and community advocates; revision of HIV treatment guidelines to include PrEP; training for HIV service providers; and establishment of drug procurement policies. These best practices can help facilitate PrEP implementation, particularly among key populations, in other country or regional programs to reduce global incidence of HIV infection.

Entities:  

Year:  2020        PMID: 32107367     DOI: 10.15585/mmwr.mm6908a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Preferences for Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence: A Discrete Choice Experiment Among Male Sex Workers in Mexico.

Authors:  Aarón Salinas-Rodríguez; Sandra G Sosa-Rubí; Carlos Chivardi; Roxana Rodríguez-Franco; Monica Gandhi; Kenneth H Mayer; Don Operario; Nathalie Gras-Allain; Galileo Vargas-Guadarrama; Omar Galárraga
Journal:  AIDS Behav       Date:  2021-08-27

2.  Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP.

Authors:  Rachel Kawuma; Andrew Sentoogo Ssemata; Sarah Bernays; Janet Seeley
Journal:  SSM Popul Health       Date:  2021-01-30

3.  Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda.

Authors:  Timothy R Muwonge; Rogers Nsubuga; Norma C Ware; Monique A Wyatt; Emily Pisarski; Brenda Kamusiime; Vicent Kasiita; Grace Kakoola Nalukwago; Charles Brown; Agnes Nakyanzi; Monica Bagaya; Felix Bambia; Timothy Ssebuliba; Elly Katabira; Peter Kyambadde; Jared M Baeten; Renee Heffron; Connie Celum; Andrew Mujugira; Jessica E Haberer
Journal:  Front Public Health       Date:  2022-04-04

4.  PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial.

Authors:  Renee Heffron; Timothy R Muwonge; Katherine K Thomas; Florence Nambi; Lylianne Nakabugo; Joseph Kibuuka; Dorothy Thomas; Erika Feutz; Allison Meisner; Norma C Ware; Monique A Wyatt; Jane M Simoni; Ingrid T Katz; Herbert Kadama; Jared M Baeten; Andrew Mujugira
Journal:  EClinicalMedicine       Date:  2022-08-11

5.  Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.

Authors:  Patrick Owuor Mbullo; Lisa Ruth Hirschhorn; Maya Jackson-Gibson; Ashley Uzoamaka Ezema; Wicklife Orero; Irene Were; Ramael Osasogie Ohiomoba
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

Review 6.  Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa.

Authors:  Daniel K Were; Abednego Musau; Kaitlyn Atkins; Prakriti Shrestha; Jason Reed; Kelly Curran; Diwakar Mohan
Journal:  Lancet HIV       Date:  2021-07-12       Impact factor: 16.070

7.  Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda.

Authors:  Timothy R Muwonge; Rogers Nsubuga; Charles Brown; Agnes Nakyanzi; Monica Bagaya; Felix Bambia; Elly Katabira; Peter Kyambadde; Jared M Baeten; Renee Heffron; Connie Celum; Andrew Mujugira; Jessica E Haberer
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.